Barosense looks to raise $30M to market obesity device
Barosense, creator of a minimally-invasive device that can treat obesity, has announced its intent to raise $30 million in a fourth round of funding to commercialize its product. Already many of its existing investors have pledged to provide half that amount, including Delphi Ventures, Frazier Healthcare Ventures, Invesco Private Capital, RWI Ventures, Synergy Life Science Partners and Wharton Ventures.
Based in Menlo Park, Calif., Barosense says it expects to close this round by the end of June. It finished off its product development earlier this year, with help from an $11 million round of capital raised in 2007. The company plans to have it on the market by 2010.
Next Story: New Leaf Paper raises $5M to produce sustainable paper products
Previous Story: Neuraltus scores $17M to treat degenerative brain disease
About the Author, Camille Ricketts
Camille is the lead writer for GreenBeat. She came to VentureBeat from Google where she worked on its traditional platforms team, particularly in TV. Before that, she was a reporter for the Wall Street Journal in New York and London. Follow her on Twitter at @camillericketts, and follow VentureBeat on Twitter at @venturebeat.
With GreenBeat 2009, VentureBeat's all-star conference on all things Smart Grid, coming up in November, Camille will be expanding coverage of this exciting space. Stay up to date by following @greenbeat2009 on Twitter or by becoming a fan of the event on Facebook here.